Stem Cell Research Attracts Higher Stock Trading Volumes

Advanced Cell Tech., Stem Cell Company, has seen higher stock trading volumes in Phase 1 of its stem cell research program. The company applies stem cell-based technologies and other proprietary methods in the area of regenerative medicine to bring patient-specific therapies from the lab to the bedside.

In the phase 1 of its RPE program, ACTC sees increase in the stock trading volumes. Advanced Cell Technology, Inc. is a stem cell company that specializes in the development of cellular therapies for the treatment of rare and common diseases. The company applies stem cell based technologies and other proprietary methods in the area of regenerative medicine.